Journal of Vascular and Interventional Radiology
Volume 20, Issue 1 , Pages 30-38 , January 2009

Radiologic Monitoring of Hepatocellular Carcinoma Tumor Viability after Transhepatic Arterial Chemoembolization: Estimating the Accuracy of Contrast-enhanced Cross-sectional Imaging with Histopathologic Correlation

  • Stephen J. Hunt, MD, PhD

      Affiliations

    • Department of Biological Sciences, Stanford University School of Medicine, MC 5642, 300 Pasteur Drive, Stanford, CA 94305
    • ,
  • Woojin Yu, MD

      Affiliations

    • Department of Pathology, Columbia Presbyterian Medical Center, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
    • ,
  • Joshua Weintraub, MD

      Affiliations

    • Division of Interventional and Vascular Radiology, Department of Radiology, Mount Sinai School of Medicine, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
    • ,
  • Martin R. Prince, MD, PhD

      Affiliations

    • Department of Radiology, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
    • ,
  • Nishita Kothary, MD

      Affiliations

    • Division of Interventional Radiology, Department of Radiology, Stanford University School of Medicine, MC 5642, 300 Pasteur Drive, Stanford, CA 94305
    • Corresponding Author InformationAddress correspondence to N.K.

Received 2 October 2007 ,Revised 25 September 2008 ,Accepted 26 September 2008.

References 

  1. Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54
  2. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  3. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739
  4. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–442
  5. Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80(suppl):S113–S119
  6. Llovet JM. Expanding HCC criteria for liver transplant: the urgent need for prospective, robust data. Liver Transpl. 2006;12:1741–1743
  7. Filmus J, Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn. 2004;8:207–212
  8. Tanaka K, Inoue S, Numata K, et al. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization. AJR Am J Roentgenol. 1992;158:541–546
  9. Catalano O, Esposito M, Lobianco R, Cusati B, Altei F, Siani A. Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced doppler ultrasonography. Cardiovasc Intervent Radiol. 1999;22:486–492
  10. Hosoki T, Yosioka Y, Matsubara T, et al. Power Doppler sonography of hepatocellular carcinoma treated by transcatheter arterial chemoembolization (Assessment of the therapeutic effect). Acta Radiol. 1999;40:639–643
  11. Kubota K, Hisa N, Nishikawa T, et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging. 2001;26:184–190
  12. Yoshioka H, Nakagawa K, Shindou H, et al. MR imaging of the liver before and after transcatheter hepatic chemo-embolization for hepatocellular carcinoma. Acta Radiol. 1990;31:63–67
  13. Murakami T, Nakamura H, Hori S, et al. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil (Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA). Acta Radiol. 1993;34:399–403
  14. Yamashita Y, Yoshimatsu S, Sumi M, Harada M, Takahashi M. Dynamic MR imaging of hepatoma treated by transcatheter arterial embolization therapy: assessment of treatment effect. Acta Radiol. 1993;34:303–308
  15. Winter TC, Takayasu K, Muramatsu Y, et al. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology. 1994;192:379–387
  16. Ito K, Honjo K, Fujita T, et al. Therapeutic accuracy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology. J Comput Assist Tomogr. 1995;19:198–203
  17. Kim T, Murakami T, Oi H, et al. Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr. 1995;19:948–954
  18. Castrucci M, Sironi S, De Cobelli F, Salvioni M, Del Maschio A. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imaging. 1996;21:488–494
  19. Yan FH, Zhou KR, Cheng JM, et al. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World J Gastroenterol. 2002;8:658–662
  20. Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging. 2004;19:598–604
  21. Zhao JG, Feng GS, Kong XQ, Li X, Li MH, Cheng YS. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. World J Gastroenterol. 2004;10:1152–1156
  22. Kamel IR, Bluemke DA, Eng J, et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2006;17:505–512
  23. Takayasu K, Moriyama N, Muramatsu Y, et al. Hepatic arterial embolization for hepatocellular carcinoma: comparison of CT scans and resected specimens. Radiology. 1984;150:661–665
  24. Murayama S, Tsukamoto Y, Watanabe H, Nakata H. Computed tomography of residual hepatomas following transcatheter arterial embolization. J Comput Assist Tomogr. 1986;10:969–972
  25. Muramatsu Y, Takayasu K, Moriyama N, et al. Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology. 1986;160:49–52
  26. Jinno K, Moriwaki S, Tanada M, Wada T, Mandai K, Okada Y. Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol. 1992;31(suppl):S7–S12
  27. Choi BI, Kim HC, Han JK, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology. 1992;182:709–713
  28. Imaeda T, Yamawaki Y, Seki M, et al. Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol. 1993;16:209–213
  29. Nishimine K, Uchida H, Matsuo N, et al. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol. 1994;33(suppl):S60–S68
  30. Hori M, Murakami T, Kim T, et al. Sensitivity of double-phase helical CT during arterial portography for detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 1998;22:861–867
  31. Takayasu K, Arii S, Matsuo N, et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 2000;175:699–704
  32. Vogl TJ, Trapp M, Schroeder H, et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology. 2000;214:349–357
  33. Kim HC, Kim AY, Han JK, et al. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology. 2002;225:773–780
  34. Ebied OM, Federle MP, Carr BI, et al. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 2003;97:1042–1050
  35. Guan YS, Zheng XH, Zhou XP, et al. Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Gastroenterol. 2004;10:2127–2129
  36. Jang MK, Lee HC, Kim IS, et al. Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization. J Gastroenterol Hepatol. 2004;19:1074–1080
  37. Chung YH. A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology. 2005;48:46–51
  38. Jang KM, Choi D, Lim HK, et al. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images. Korean J Radiol. 2005;6:153–160
  39. Kim SH, Lee WJ, Lim HK, Lim JH. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography. J Comput Assist Tomogr. 2007;31:198–203
  40. Tanaka K, Numata K, Okazaki H, Nakamura S, Inoue S, Takamura Y. Diagnosis of portal vein thrombosis in patients with hepatocellular carcinoma: accuracy of color Doppler sonography compared with angiography. AJR Am J Roentgenol. 1993;160:1279–1283
  41. Cioni D, Lencioni R, Bartolozzi C. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound. Eur Radiol. 2000;10:1570–1575
  42. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology. 1994;190:853–856
  43. Oi H, Murakami T, Kim T, Matsushita M, Kishimoto H, Nakamura H. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AJR Am J Roentgenol. 1996;166:369–374
  44. Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS. Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology. 1997;203:737–742
  45. Kim MJ, Mitchell DG, Ito K, Kim PN. Hepatic MR imaging: comparison of 2D and 3D gradient echo techniques. Abdom Imaging. 2001;26:269–276

 From the SIR 2006 Annual Meeting.

 None of the authors have identified a conflict of interest.

PII: S1051-0443(08)00897-X

doi: 10.1016/j.jvir.2008.09.034

Journal of Vascular and Interventional Radiology
Volume 20, Issue 1 , Pages 30-38 , January 2009

Article Tools

* Image Usage & Resolution